Second primary malignancies in head and neck cancer patients: high prevalence of curable-stage disease.
Wolff HA, Wolff CR, Hess CF, Jung K, Sennhenn-Kirchner S, Hinterthaner M, Müller-Dornieden A, Körber W, Marten-Engelke K, Roedel R, Christiansen H, Engelke C.
Wolff HA, et al. Among authors: jung k.
Strahlenther Onkol. 2013 Oct;189(10):874-80. doi: 10.1007/s00066-013-0404-4. Epub 2013 Jul 12.
Strahlenther Onkol. 2013.
PMID: 23842636